171 related articles for article (PubMed ID: 31090975)
1. The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.
Mann JE; Kulkarni A; Birkeland AC; Kafelghazal J; Eisenberg J; Jewell BM; Ludwig ML; Spector ME; Jiang H; Carey TE; Brenner JC
Head Neck; 2019 Sep; 41(9):3114-3124. PubMed ID: 31090975
[TBL] [Abstract][Full Text] [Related]
2. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Birkeland AC; Yanik M; Tillman BN; Scott MV; Foltin SK; Mann JE; Michmerhuizen NL; Ludwig ML; Sandelski MM; Komarck CM; Carey TE; Prince ME; Bradford CR; McHugh JB; Spector ME; Brenner JC
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):559-67. PubMed ID: 27077364
[TBL] [Abstract][Full Text] [Related]
3. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.
Ludwig ML; Kulkarni A; Birkeland AC; Michmerhuizen NL; Foltin SK; Mann JE; Hoesli RC; Devenport SN; Jewell BM; Shuman AG; Spector ME; Carey TE; Jiang H; Brenner JC
Oral Oncol; 2018 Dec; 87():144-151. PubMed ID: 30527230
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
5. Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Smith JD; Birkeland AC; Rosko AJ; Hoesli RC; Foltin SK; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Wolf GT; Bradford CR; Prince ME; Brenner JC; Spector ME
Head Neck; 2019 Feb; 41(2):423-428. PubMed ID: 30548484
[TBL] [Abstract][Full Text] [Related]
6. Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
Todorova TA; Jordanov SH; Stancheva GS; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Pathol Oncol Res; 2015 Apr; 21(2):413-21. PubMed ID: 25149524
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
8. Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.
Bednarek K; Kiwerska K; Szaumkessel M; Bodnar M; Kostrzewska-Poczekaj M; Marszalek A; Janiszewska J; Bartochowska A; Jackowska J; Wierzbicka M; Grenman R; Szyfter K; Giefing M; Jarmuz-Szymczak M
Tumour Biol; 2016 Aug; 37(8):11115-26. PubMed ID: 26912061
[TBL] [Abstract][Full Text] [Related]
9. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
[TBL] [Abstract][Full Text] [Related]
10. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
[TBL] [Abstract][Full Text] [Related]
11. The non-coding landscape of head and neck squamous cell carcinoma.
Zou AE; Zheng H; Saad MA; Rahimy M; Ku J; Kuo SZ; Honda TK; Wang-Rodriguez J; Xuan Y; Korrapati A; Yu V; Singh P; Grandis JR; King CC; Lippman SM; Wang XQ; Hinton A; Ongkeko WM
Oncotarget; 2016 Aug; 7(32):51211-51222. PubMed ID: 27323410
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.
Li H; Wawrose JS; Gooding WE; Garraway LA; Lui VW; Peyser ND; Grandis JR
Mol Cancer Res; 2014 Apr; 12(4):571-82. PubMed ID: 24425785
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
14. Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines.
Giefing M; Martin-Subero JI; Kiwerska K; Jarmuz M; Grenman R; Siebert R; Szyfter K
Cancer Genet Cytogenet; 2008 Jul; 184(1):38-43. PubMed ID: 18558287
[TBL] [Abstract][Full Text] [Related]
15. Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.
Kostrzewska-Poczekaj M; Giefing M; Jarmuz M; Brauze D; Pelinska K; Grenman R; Bartochowska A; Szyfter W; Szyfter K
Cancer Biomark; 2010-2011; 8(1):11-9. PubMed ID: 21896986
[TBL] [Abstract][Full Text] [Related]
16. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
17. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
Fang W; Shen J
Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
[TBL] [Abstract][Full Text] [Related]
18. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
[TBL] [Abstract][Full Text] [Related]
19. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease.
Nisa L; Barras D; Medová M; Aebersold DM; Medo M; Poliaková M; Koch J; Bojaxhiu B; Eliçin O; Dettmer MS; Angelino P; Giger R; Borner U; Caversaccio MD; Carey TE; Ho L; McKee TA; Delorenzi M; Zimmer Y
Mol Cancer Res; 2018 Dec; 16(12):1912-1926. PubMed ID: 30108165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
